Press Releases Eli Lilly and Company

Equities

LLY

US5324571083

Delayed Nyse Other stock markets 04:00:02 2024-05-24 pm EDT			5-day change	1st Jan Change
807.4 ^USD	-0.13%		+4.86%	+38.51%

01:17pm	News Highlights : Top Company News of the Day - Monday at 7 AM ET	DJ
11:15am	News Highlights : Top Company News of the Day - Monday at 5 AM ET	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Major manufacturing investment to support API production for tirzepatide	04:31am	AQ
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro	May. 24	AQ
Eli Lilly and : 2015 Global Health Programs Report	May. 24	PU
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines	May. 24	PR
Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise, Tuesday, 5/21/2024	May. 21	AQ
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	May. 21	AQ
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin	May. 16	PR
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer	May. 15	PR
Eli Lilly and : Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation	May. 14	PU
Eli Lilly and : Lilly Statement on FDA Advisory Committee Meeting on Donanemab for Early Symptomatic Alzheimer’s Disease	May. 07	PU
Lilly Declares Second-Quarter 2024 Dividend	May. 06	PR
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024	Apr. 30	AQ
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues	Apr. 30	AQ
Eli Lilly and : Q1 Earnings 2024 Press Release	Apr. 30	PU
Eli Lilly and : Q1 Earnings 2024 Earnings Presentation	Apr. 30	PU
Lilly: Q1 Earnings Snapshot	Apr. 30	AQ
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum	Apr. 30	PR
Eli Lilly and : Lilly Recommends Shareholders Reject “Mini-Tender” Offer by Tutanota LLC	Apr. 26	PU
ProQR Highlights Upcoming Presentations on Axiomer RNA Editing at ASGCT 27th Annual Meeting	Apr. 23	AQ
Eli Lilly and : Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals	Apr. 22	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT